Cargando…

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION

Detalles Bibliográficos
Autores principales:	Sridhar, Amrutha, Chavda, Selina, Hsu, Hannah, Renshaw, Hanna, Fernandes, Tatianna, Maciter, Catriona, Asher, Samir, Rabin, Neil, Sive, Jonathan, Kyriakou, Charalampia, Papanikolaou, Xenofon, Xu, Ke, Wechalekar, Ashutosh, Mahmood, Shameem, Mcmillan, Annabel, Lee, Lydia, Yong, Kwee, Dekaj, Fatjon, Popat, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429521/ http://dx.doi.org/10.1097/01.HS9.0000975156.81209.72

Ejemplares similares

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma
por: Asher, Samir, et al.
Publicado: (2022)

OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines
por: Chan, Wei Yee, et al.
Publicado: (2021)

Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors
por: Chan, Wei Yee, et al.
Publicado: (2021)

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
por: Lecat, Catherine S. Y., et al.
Publicado: (2021)

PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE IN 653 PATIENTS.
por: Kanellias, Nikolaos, et al.
Publicado: (2023)

Deferred autologous stem cell transplantation in systemic AL amyloidosis
por: Manwani, Richa, et al.
Publicado: (2018)

The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study
por: Camilleri, Marquita, et al.
Publicado: (2022)

High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
por: Koutoukidis, Dimitrios A., et al.
Publicado: (2020)

Rhinitis, sinusitis and ocular disease – 2091. The MSYPQ: repeatability and applicability to rhinitis/rhinosinusitis
por: Sami, Amtul Salam, et al.
Publicado: (2013)

PReS-FINAL-2091: Extra-articular calcification after intra-articular corticosteroid injection
por: Toftedal, P, et al.
Publicado: (2013)

2091: Evaluating the validity and utility of surrogate endpoints in clinical trials of chronic kidney disease (CKD)
por: Ying, Jian, et al.
Publicado: (2018)

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022)

2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
por: Kwon, Ki Tae, et al.
Publicado: (2018)

2091 Neurophysiological substrates and developmental sequelae of sensory differences in infants at high risk for autism spectrum disorder
por: Woynaroski, Tiffany G., et al.
Publicado: (2018)

2091. Use of Telehealth to Expand Antimicrobial Stewardship Capacity Among Critical Access Hospitals in Washington State
por: Kvak, Staci, et al.
Publicado: (2019)

P918: HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS
por: Khwaja, J., et al.
Publicado: (2022)

Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing
por: Malhotra, Karan, et al.
Publicado: (2016)

Correction: Lu et al. Performance Analysis of Metalenses Based on Three Kinds of Phase Compensation Techniques. Nanomaterials 2021, 11, 2091
por: Lu, Peiyao, et al.
Publicado: (2023)

Novel mutation c.2090_2091del in neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities in an 18.5-mo-old boy: A case report
por: Li, Yi, et al.
Publicado: (2023)

A rare case of relapsed multiple myeloma with aberrant T‐cell antigen expression and skin plasmacytomas
por: Lecat, Catherine S.Y., et al.
Publicado: (2021)

Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival
por: Chin, M, et al.
Publicado: (2017)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Thoracic amyloidomas: Two case reports of an evasive diagnosis
por: Cresner, Rosie, et al.
Publicado: (2014)

Systematic literature review of quality‐of‐life questionnaires in Waldenström macroglobulinaemia—need for a disease‐specific tool
por: Bristogiannis, Sotirios, et al.
Publicado: (2023)

Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
por: Leti, Fatjon, et al.
Publicado: (2017)

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response
por: Latifoltojar, Arash, et al.
Publicado: (2016)

Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy
por: Cook, Gordon, et al.
Publicado: (2020)

Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications
por: Haverick, Mark, et al.
Publicado: (2014)

A GIS-aided cellular automata system for monitoring and estimating graph-based spread of epidemics
por: Kyriakou, Charilaos, et al.
Publicado: (2022)

P910: DISPARATE PREDICTION OF OUTCOMES IN A UNIFORMLY TREATED COHORT OF PATIENTS WITH AL AMYLOIDOSIS STRATIFIED BY MAYO 2012 AND EUROPEAN CARDIAC STAGING SYSTEMS
por: Khwaja, Jahanzaib, et al.
Publicado: (2023)

Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Monitoring Female Fertility Through ‘Femtech’: The Need for a Whole-System Approach to Regulation
por: McMillan, Catriona
Publicado: (2022)

‘Model’ or ‘tool’? New definitions for translational research
por: Sive, Hazel
Publicado: (2011)

Bayesian Sigmoid-Type Time Series Forecasting with Missing Data for Greenhouse Crops
por: Kocian, Alexander, et al.
Publicado: (2020)

Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
por: Jordan, Karin, et al.
Publicado: (2013)

Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia
por: Atrash, Shebli, et al.
Publicado: (2017)

SATB2 loss in inflammatory bowel disease-associated small intestinal metaplasia of the distal colon
por: Zeineldin, Maged, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gkd4l9m4rnpb6mfeupvau5k4vk